07.04.2010 • NewsAkzoNobelIndiaICI

Akzo Nobel Rebrands Indian ICI business

Akzo Nobel's integration activities following the acquisition of ICI have reached a significant landmark with the ICI India business now officially known as Akzo Nobel India Limited. ICI India, a separate listed company on the stock market, is one of the country's leading decorative paints businesses. Led by Managing Director Amit Jain under the same Board of Directors, the rebranded business will continue to play a pivotal role in the company's strategic growth plans.

"We are delighted that ICI India has now officially taken on the AkzoNobel name," said CEO Hans Wijers. "India is a very important market for us and we are now well prepared to take full advantage of the world class capabilities of our Indian decorative paints organization and build on our promising market position."

He added that AkzoNobel plans to make major investments in India during the next five years to boost the opportunities in this high-growth market. "The change in identity is just the beginning of a wave of strategic investments which we plan to make in people, practices, new ways of marketing, technology and research," continued Wijers.

Company

Logo:

AkzoNobel

Christian Neefestraat 2
1077 WW Amsterdam
Netherlands

Company contact







Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.